News and Trends 19 Dec 2016 Evotec closes the year partnering with Celgene to treat Alzheimer’s Evotec is closing a fantastic financial year with another top-level partnership; Celgene has decided to trust in its iPSC platform to develop drugs for neurodegenerative diseases. Evotec is a successful drug discovery CRO based in Germany that has managed to sign partnerships with some of the biggest names in Biotech. In addition to previous deals with Bayer, Merck, […] December 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2016 Why don’t more Biotech Startups Succeed? Merck might have a Solution Merck is supporting startups with its Emerging Biotech Initiative, which grants winners up to €100K in products and services. As the number of R&D projects started by biotech companies and academic institutions increases, biotech is proving itself to be a vital part of medicine. So what’s holding startups back? Funding trouble is one of the […] December 19, 2016 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2016 Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments? Hopes for an Alzheimer’s cure took a hit with Eli Lilly’s recent failure, but it’s not over yet. Probiodrug explains the failure and response. Alzheimer’s Disease devastates families and represents one of the largest financial burdens in society. Now the sixth leading cause of death for all age groups, the neurodegenerative disease cost the US […] December 19, 2016 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 17 Dec 2016 Microbial Dresses and a Dishcloth that tells you it’s Time to Wash it From microbial fashion to a fabric that changes colors in the presence of pathogens, Neffa is exploring the many benefits and applications of combining microbiology and textiles. Aniela Hoitink is an artist based in Amsterdam that specializes in incorporating microbiology into textiles. Her trademark Neffa englobes a series of projects that seek to translate innovations in these […] December 17, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 16 Dec 2016 Mini-Organs grown in Switzerland are Here to Change Drug Discovery This week we travel to Lausanne, a thriving biotech hub in Switzerland. Here, QGel is working to replicate the complexity of life in vitro in lab-grown mini-organs to improve drug discovery. Cool, right? City: Lausanne, Switzerland Founded: 2009 Employees: 11-50 Financial data: Total of €12M raised (12/2016) Mission: QGel creates personalized arrays that can mimic the cellular architecture of different organs. […] December 16, 2016 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 16 Dec 2016 This Gene Therapy Startup is Showing Off with a Better Viral Vector GeneQuine wants to be one of the first to use gene therapy to treat osteoarthritis! Watch Kilian Guse’s pitch at Labiotech Refresh to find out how his startup plans to do this. “Osteoarthritis is the most common joint disorder. (…) Currently, there are only symptomatic treatments but no disease-modifying treatment“. One of the major challenges is efficient drug […] December 16, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 16 Dec 2016 Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis Amcure and TILT Biotherapeutics announced yesterday new financing rounds supporting the development of unique strategies to cure cancer metastasis. Amcure, in Germany, is fighting highly metastatic forms of cancer by targeting angiogenesis. The company just closed a Series B round with a total of €6M from already existing investors. With the funds, Amcure plans to accelerate […] December 16, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2016 Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials Kiadis Pharma has received approval to test in the UK an immune therapy to address the big challenges of bone marrow transplants, currently the only cure for blood cancers. Kiadis Pharma, based in Amsterdam, is working on therapies to improve the outcome of hematopoietic stem cell transplantation (HSCT), a common treatment for multiple types of […] December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2016 This Biofuel Company partnered with Audi is about to shake the Oil Market At Labiotech Refresh we had the opportunity to chat with Marc Delcourt, founder and CEO of Global Bioenergies, a biofuel pioneer challenging the oil market. Global Bioenergies, from France, uses synthetic biology to produce isobutene, the “building block of the chemical industry“. This molecule, currently extracted from oil, is essential for the manufacturing of gasoline, rubber, […] December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2016 UPDATE: European Stem Cell Therapy Pioneer goes for €34M IPO TiGenix is entering the Nasdaq with an IPO aimed at funding clinical trials. Will this move allow the company to make it through clinical trials? TiGenix is a Belgian company behind ChondroCellect, the first cell therapy approved on the European market. The biotech has now announced a Nasdaq IPO that aims to raise €39.8M in order to fund […] December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2016 10 Awesome Biotech Gifts for you and your Geekiest Loved Ones Stuck on what to get your family and friends for Christmas? What about portable lab equipment or a stuffed version of your favorite microorganism? Biotech is one of the fastest growing sectors worldwide and a big employer in Europe. Providing solutions to cure, feed and fuel the world, who wouldn’t want to brag about this amazing field? Whether […] December 15, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2016 Deloitte’s Message to Pharma: Learn from Biotech or Perish The consulting firm’s annual financial report suggests pharma’s current model is not sustainable. The solution? Be more like biotech. Pharma has had a rollercoaster of a year, from anxiety about the US election to stellar CAR-T results after patient deaths. Overall, however, the numbers have not been great, and a new report from the analysts at […] December 14, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email